Terms: = Prostate cancer AND HEY1, CHF-2, 23462, ENSG00000164683, HESR1, CHF2, HESR-1, MGC1274, HRT-1, OAF1, HERP2
14 results:
1. Knocking down SOX2 overcomes the resistance of prostate cancer to castration via notch signaling.
Du Z; Chen X; Zhu P; Lv Q; Yong J; Gu J
Mol Biol Rep; 2023 Nov; 50(11):9007-9017. PubMed ID: 37716921
[TBL] [Abstract] [Full Text] [Related]
2. Design, synthesis and SAR study of Fluorine-containing 3rd-generation taxoids.
Wang C; Chen L; Sun Y; Guo W; Taouil AK; Ojima I
Bioorg Chem; 2022 Feb; 119():105578. PubMed ID: 34979464
[TBL] [Abstract] [Full Text] [Related]
3. NKX3.1 immunohistochemistry is highly specific for the diagnosis of mesenchymal chondrosarcomas: experience in the Australian population.
Ramanayake N; Vargas AC; Talbot J; Bonar F; Wong DD; Wong D; Mahar A; Karim R; Luk PP; Selinger C; Sioson L; Gill AJ; Maclean F
Pathology; 2021 Oct; 53(6):705-712. PubMed ID: 33640159
[TBL] [Abstract] [Full Text] [Related]
4. HES6 promotes prostate cancer aggressiveness independently of Notch signalling.
Carvalho FL; Marchionni L; Gupta A; Kummangal BA; Schaeffer EM; Ross AE; Berman DM
J Cell Mol Med; 2015 Jul; 19(7):1624-36. PubMed ID: 25864518
[TBL] [Abstract] [Full Text] [Related]
5. Notch signaling in prostate cancer: a moving target.
Carvalho FL; Simons BW; Eberhart CG; Berman DM
Prostate; 2014 Jun; 74(9):933-45. PubMed ID: 24737393
[TBL] [Abstract] [Full Text] [Related]
6. prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and hey1 notch targets genes and promotes prostate cancer progression.
Alaña L; Sesé M; Cánovas V; Punyal Y; Fernández Y; Abasolo I; de Torres I; Ruiz C; Espinosa L; Bigas A; Y Cajal SR; Fernández PL; Serras F; Corominas M; Thomson TM; Paciucci R
Mol Cancer; 2014 Mar; 13():74. PubMed ID: 24684754
[TBL] [Abstract] [Full Text] [Related]
7. Notch activation is dispensable for D, L-sulforaphane-mediated inhibition of human prostate cancer cell migration.
Hahm ER; Chandra-Kuntal K; Desai D; Amin S; Singh SV
PLoS One; 2012; 7(9):e44957. PubMed ID: 22970326
[TBL] [Abstract] [Full Text] [Related]
8. Notch signaling modulates hypoxia-induced neuroendocrine differentiation of human prostate cancer cells.
Danza G; Di Serio C; Rosati F; Lonetto G; Sturli N; Kacer D; Pennella A; Ventimiglia G; Barucci R; Piscazzi A; Prudovsky I; Landriscina M; Marchionni N; Tarantini F
Mol Cancer Res; 2012 Feb; 10(2):230-8. PubMed ID: 22172337
[TBL] [Abstract] [Full Text] [Related]
9. Repression of androgen receptor activity by HEYL, a third member of the Hairy/Enhancer-of-split-related family of Notch effectors.
Lavery DN; Villaronga MA; Walker MM; Patel A; Belandia B; Bevan CL
J Biol Chem; 2011 May; 286(20):17796-808. PubMed ID: 21454491
[TBL] [Abstract] [Full Text] [Related]
10. Notch-1 signaling is lost in prostate adenocarcinoma and promotes PTEN gene expression.
Whelan JT; Kellogg A; Shewchuk BM; Hewan-Lowe K; Bertrand FE
J Cell Biochem; 2009 Aug; 107(5):992-1001. PubMed ID: 19479935
[TBL] [Abstract] [Full Text] [Related]
11. Mechanisms of androgen receptor repression in prostate cancer.
Powell SM; Brooke GN; Whitaker HC; Reebye V; Gamble SC; Chotai D; Dart DA; Belandia B; Bevan CL
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1124-7. PubMed ID: 17073766
[TBL] [Abstract] [Full Text] [Related]
12. Low-calcium serum-free defined medium selects for growth of normal prostatic epithelial stem cells.
Litvinov IV; Vander Griend DJ; Xu Y; Antony L; Dalrymple SL; Isaacs JT
Cancer Res; 2006 Sep; 66(17):8598-607. PubMed ID: 16951173
[TBL] [Abstract] [Full Text] [Related]
13. Comparative genomics on HHIP family orthologs.
Katoh Y; Katoh M
Int J Mol Med; 2006 Feb; 17(2):391-5. PubMed ID: 16391842
[TBL] [Abstract] [Full Text] [Related]
14. hey1, a mediator of notch signaling, is an androgen receptor corepressor.
Belandia B; Powell SM; García-Pedrero JM; Walker MM; Bevan CL; Parker MG
Mol Cell Biol; 2005 Feb; 25(4):1425-36. PubMed ID: 15684393
[TBL] [Abstract] [Full Text] [Related]
